Furtherly, DYNLL1-AS1, upregulated in the plasma of ESCC patients after radiotherapy and ESCC tissues, may be a prognostic marker and a therapeutic target in ESCC. This evidence concerns the gene DYNLL1 and esophageal squamous cell carcinoma.